F2G
Mark Bresnik, MD has over 38 years of experience in the medical field. In 2021, they began working at F2G as Executive Director, Clinical R&D and at MB-ID Consulting as an Infectious Diseases Consultant. In 2013, they began working as a Guest Lecturer at the University of California, Berkeley | School of Public Health. From 2001 to 2021, they worked at Gilead Sciences in various roles, including Sr. Director, Clinical Research | Lead for Tirabrutinib (inflammation/rheumatoid arthritis) and Sr. Director, Clinical Research | Advisor to AmBisome Clin Research, Med Affairs, & Regulatory teams. From 1983 to 2001, they worked at Alta Bates Summit Medical Center as Staff Physician, Medical Director, Infectious Diseases - Antibiotic Review Team (Antibiotic Stewardship), Medical Director, Infection Control | Hospital Epidemiology, Internal Medicine Hospitalist, and Medical Director, Microbiology Laboratory. Mark also worked at Bay Infectious Diseases Medical Group as an Infectious Diseases Consultant and at East Bay Aids Center-EBAC as Co-Founder and Infectious Diseases Consultant. Lastly, they worked at East Bay Internal Medicine as a General Internal Medicine Physician.
Mark Bresnik, MD obtained their Doctor of Medicine (MD) degree from the University of Illinois College of Medicine in 1978.
This person is not in any offices
F2G
1 followers
F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.